Borat Subsequent Moviefilm

Providence Medical Technology Announces New Publication Demonstrating High Fusion Rates and Successful Outcomes in Previously Failed Cervical Fusion Patients

Retrieved on: 
목요일, 12월 7, 2023
Risk factor, Neck, Research, FFS, Orthopedic surgery, Duke University, Borat Subsequent Moviefilm, FUSE, Surgeon, Immobilization, Patient, Journal, ACDF, PCF, Nonunion, Success, Pain, Bleeding, Risk, Journal of Clinical Neuroscience, Hospital, Diabetes, Motion, Smoking, Birth control, Dentistry, Pharmaceutical industry, C7, C3, Neurosurgery

PLEASANTON, Calif., Dec. 7, 2023 /PRNewswire/ -- Providence Medical Technology, Inc., a medical device innovator focused on improving surgical outcomes for high-risk spine surgery patients, today announced a new publication in the Journal of Clinical Neuroscience. Dr. Michael M. Haglund and colleagues authored the publication on the long-term outcomes of patients undergoing tissue-sparing Posterior Cervical Fusion (PCF) to revise a 1-level pseudarthrosis following a failed Anterior Cervical Discectomy and Fusion (ACDF).

Key Points: 
  • Dr. Michael M. Haglund and colleagues authored the publication on the long-term outcomes of patients undergoing tissue-sparing Posterior Cervical Fusion (PCF) to revise a 1-level pseudarthrosis following a failed Anterior Cervical Discectomy and Fusion (ACDF).
  • There are over 300,000 cervical fusion procedures performed each year, with over 40% involving patients with some form of risk factors for nonunion.
  • Our tissue-sparing posterior fusion technology is a great option to treat these patients, as is well demonstrated in this study.
  • Providence Medical Technology devices have been used to treat over 20,000 patients and are currently available in over 2,500 hospitals in the United States.

Contango ORE Announces Year End Results

Retrieved on: 
수요일, 9월 13, 2023
Mining, Minerals, Natural Resources, Exercise, Form 10-K, Coleman, Technical report, Peak gold, Kinross Gold, The Lucky Shot, Borat Subsequent Moviefilm, Security (finance), Macquarie Group, Credit, NYSE, Rare-earth element, Uranium mining

Contango ORE, Inc. (“Contango” or the “Company”) (NYSE American: CTGO) announced today it filed its Form 10-K for the year ended June 30, 2023 with the Securities and Exchange Commission.

Key Points: 
  • Contango ORE, Inc. (“Contango” or the “Company”) (NYSE American: CTGO) announced today it filed its Form 10-K for the year ended June 30, 2023 with the Securities and Exchange Commission.
  • The Company reported a net loss of $39.7 million or a loss of $5.61 per basic and diluted share for the year ended June 30, 2023 compared to a net loss of $23.5 million or a loss of $3.49 per basic and diluted share for the prior year.
  • The primary reason for the increase in net loss in 2023 is due to an increase in pre-production costs for development and construction at the Company’s 30% interest in the Manh Choh mine, which is being operated by Kinross Gold Corporation (‘Kinross”).
  • The Manh Choh mine celebrated the commencement of mining operations with a ground-breaking ceremony on August 29, 2023.

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
월요일, 5월 1, 2023
General Health, Medical Devices, Health, Pharmaceutical, Optical, GKOS, Glaucoma, Collagen, Refractive surgery, Corneal ectatic disorders, ASCRS, Retina, American Society of Cataract and Refractive Surgery, Corporation, Art, Physician, Cataract, Borat Subsequent Moviefilm, Society, NYSE, Pharmaceutical industry, Keratoconus, Ectasia

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held May 5 – 8, 2023 in San Diego, CA.

Key Points: 
  • Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held May 5 – 8, 2023 in San Diego, CA.
  • Glaukos will be exhibiting onsite at booth #1237.
    iStent inject® Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Open-Angle Glaucoma: Long-Term Results
    10-Year Follow-up for Collagen Cross-Linking in Keratoconus and Ectasia: Comparison of Outcomes with Subsequent Topography-Altering Surgery
    Customized Transepithelial Cross-Linking for Keratoconus: 2-Year Follow-up
    Keratoconus State of the Art: New Cutting-Edge Treatments for Corneal Ectasia (IC-105)
    The ASCRS Annual Meeting is among the largest gatherings of anterior segment physicians, medical personnel and industry executives in the ophthalmic industry.
  • All educational content of the ASCRS annual meeting is planned by its program committee.
  • ASCRS does not endorse, promote, approve or recommend the use of any products, devices or services.

Norfolk Southern announces six-point safety plan

Retrieved on: 
월요일, 3월 6, 2023
Federal Railroad Administration, NTSB, NYSE, Vibration, Georgia Tech Research Institute, Pressure, Intelligence, Algorithm, Vinyl chloride, Ultra, Norfolk Southern Railway, National Transportation Safety Board, Borat Subsequent Moviefilm, Australian Transport Safety Bureau, Reading, Temperature, NSC, Safety, Rail transport by country, Rail transport

ATLANTA, March 6, 2023 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) announced Monday a six-point plan to immediately enhance the safety of its operations.

Key Points: 
  • ATLANTA, March 6, 2023 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) announced Monday a six-point plan to immediately enhance the safety of its operations.
  • Norfolk Southern is evaluating the distance between hot bearing detectors, which currently averages 13.9 miles on its core network.
  • Norfolk Southern is working with manufacturers to accelerate the testing and deployment of safety technology on its network that can scan a greater cross-section of a railcar's bearings and wheels.
  • In addition to enhancing its use of hot bearing detectors, Norfolk Southern will immediately accelerate the deployment of acoustic bearing detectors, which play a different role in its safety inspection program.

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

Retrieved on: 
수요일, 2월 22, 2023
Maintenance, NORA, Congress, Development, ESMO, Shanghai Cancer Center, III, Placebo, MD, PDS, European Society for Medical Oncology, ADP, Ovarian cancer, Peking Union Medical College, Survival, Data analysis, OS, MOS, Peking Union Medical College Hospital, Mutation, Progression-free survival, ISD, IDS, Fudan University, Medicine, Borat Subsequent Moviefilm, PFS, Oncology, Pharmaceutical industry, Patient, Niraparib

One presentation will feature an ad hoc interim OS data analysis of the Phase 3 NORA trial, showing how niraparib maintenance therapy with an individualized starting dose (ISD) provided a favorable OS (OS; secondary endpoint) trend versus placebo in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC) regardless of biomarker status.

Key Points: 
  • One presentation will feature an ad hoc interim OS data analysis of the Phase 3 NORA trial, showing how niraparib maintenance therapy with an individualized starting dose (ISD) provided a favorable OS (OS; secondary endpoint) trend versus placebo in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC) regardless of biomarker status.
  • The median overall survival (mOS) in the niraparib-treated group was numerically higher (46.3 months) compared to 43.4 months in placebo [HR=0.82; 95% CI, 0.56-1.21].
  • This new data analysis explores the treatment effect of niraparib versus placebo on OS adjusted for subsequent poly (ADP-ribose) polymerase inhibitor (PARPi) use in the placebo group.
  • Another presentation will feature a post hoc analysis from the randomized, double-blind, placebo-controlled Phase 3 PRIME trial, with results showing niraparib associated with improved progression-free survival (PFS) regardless of surgical timing and residual disease status compared with placebo in patients with newly diagnosed advanced ovarian cancer in China.

Mobile Fuel Delivery Market Gaining Ground as Fuel Prices Fall

Retrieved on: 
화요일, 8월 30, 2022
Storm, CEO, Exxon, Securities Act of 1933, Research, Spire Inc, Dery, Corrosion, Partnership, News, ANY, GM, Energy Independence and Security Act of 2007, Gulf of Mexico, NEVER, HDPE, Freedom, U.S. Securities and Exchange Commission, FNM, Population, SR, NOT, Time, Lubricant, CFO, Transport, Farm, Wheeler, WTI, Annual report, PALM, Security (finance), Securities Exchange Act of 1934, Form 10-K, NASDAQ, Stainless steel, Water, Mitsubishi, MUR, NEWS, Private Securities Litigation Reform Act, Growth, Aviation, Borat Subsequent Moviefilm, Marathon Oil, Consumer, NYSE, MRO, Murphy Oil, Manatee, Fiscal, Shell, NGL, Forward-looking statement, Natural gas, Propane, Airline, Renewable energy, Oil, Rocky Mountains, Tampa Bay

Mobile fueling is a service where a fuel delivery company delivers fuel on-site for trucks, equipment, boats, cars or machinery.

Key Points: 
  • Mobile fueling is a service where a fuel delivery company delivers fuel on-site for trucks, equipment, boats, cars or machinery.
  • A recent report predicted growth in the market: "Mobile fuel storage tanks are used for transportation and storage of fuel and other industrial fluids to remote service areas, whether in-shop or in-field.
  • The mobile fuel storage tank market is segmented into the material and end-user segment.
  • Fracking and transportation of gas drive the demand for the mobile fuel storage tank market in the projected period.

Mobile Fuel Delivery Market Gaining Ground as Fuel Prices Fall

Retrieved on: 
화요일, 8월 30, 2022
Storm, CEO, Exxon, Securities Act of 1933, Research, Spire Inc, Dery, Corrosion, Partnership, News, ANY, GM, Energy Independence and Security Act of 2007, Gulf of Mexico, NEVER, HDPE, Freedom, U.S. Securities and Exchange Commission, FNM, Population, SR, NOT, Time, Lubricant, CFO, Transport, Farm, Wheeler, WTI, Annual report, PALM, Security (finance), Securities Exchange Act of 1934, Form 10-K, NASDAQ, Stainless steel, Water, Mitsubishi, MUR, NEWS, Private Securities Litigation Reform Act, Growth, Aviation, Borat Subsequent Moviefilm, Marathon Oil, Consumer, NYSE, MRO, Murphy Oil, Manatee, Fiscal, Shell, NGL, Forward-looking statement, Natural gas, Propane, Airline, Renewable energy, Oil, Rocky Mountains, Tampa Bay

Mobile fueling is a service where a fuel delivery company delivers fuel on-site for trucks, equipment, boats, cars or machinery.

Key Points: 
  • Mobile fueling is a service where a fuel delivery company delivers fuel on-site for trucks, equipment, boats, cars or machinery.
  • A recent report predicted growth in the market: "Mobile fuel storage tanks are used for transportation and storage of fuel and other industrial fluids to remote service areas, whether in-shop or in-field.
  • The mobile fuel storage tank market is segmented into the material and end-user segment.
  • Fracking and transportation of gas drive the demand for the mobile fuel storage tank market in the projected period.

ToughBuilt Industries Announces Second Quarter 2022 Results

Retrieved on: 
금요일, 8월 19, 2022
U.S. Securities and Exchange Commission, Risk, Industry, Forward-looking statement, GLOBE, Consumables, Germany, TBLT, Growth, SEC, Sawhorse, Amazon (company), Creativity, Hardware, Xi, Research, Annual report, Analysis, Security (finance), Compliance, Government, Marketing, Trademark dilution, Review, COVID-19, Company, Mission statement, Private placement, Work-product doctrine, NASDAQ, Financial condition report, Enteric fermentation, Borat Subsequent Moviefilm, Advertising, MD, Result, Video game, Online gambling, Risk management, Amazon

IRVINE, Calif., Aug. 19, 2022 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. ("ToughBuilt") (NASDAQ: TBLT; TBLTW), today reported financial results for the second quarter ended June 30, 2022.

Key Points: 
  • IRVINE, Calif., Aug. 19, 2022 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. ("ToughBuilt") (NASDAQ: TBLT; TBLTW), today reported financial results for the second quarter ended June 30, 2022.
  • Operating expenses were approximately $17.3 million in the second quarter of 2022, compared to approximately $10.7 million in the second quarter of 2021.
  • Net loss attributable to common stockholders in the second quarter of 2022 was approximately $12.1 million, or $9.45 per share, compared to a net loss of approximately $7.4 million, or $13.64 per share in the second quarter of 2021.
  • Second Quarter 2022 Business Highlights:
    Second quarter 2022 Amazon.com gross sales increased by 41% to approximately $3.54 million, compared to approximately $2.4 million for the second quarter of 2021.

Prospera Announces Results of Annual General Meeting of Shareholders

Retrieved on: 
목요일, 7월 7, 2022
SEDAR, Acquisition, Progress Energy Inc, Borat Subsequent Moviefilm, Director, CEO, PEI, GLOBE, Officer, Public expenditure, Mackay, Shareholder, Corporation, CFO, Proxy, Mission statement, FRA, Health, AGM, Audit committee, State Finance Accountability Committee, Board, Safety, News, Chairperson, Forward-looking statement, Holding company, Security (finance), Audit, Management, Oportunidades

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (PEI: TSX-V; OF6B: FRA) ("Prospera" or the "Corporation") shareholders voted in favor of all items of business brought before them at the Corporation's Annual General Meeting ("AGM") of Shareholders held on May 27, 2022, in Calgary.

Key Points: 
  • CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (PEI: TSX-V; OF6B: FRA) ("Prospera" or the "Corporation") shareholders voted in favor of all items of business brought before them at the Corporation's Annual General Meeting ("AGM") of Shareholders held on May 27, 2022, in Calgary.
  • Approve an ordinary resolution ratifying the Corporation's stock option plan; and
    Subsequent to the AGM, the Board appointed Mr. Samuel David as CEO & President.
  • Subsequent to this meeting the Board ratified the appointment of the following Officers: Matthew Kenna, CFO; Chris Ludtke, Vice President Finance & Accounting; George Magarian, Vice-President.
  • Actual results could differ materially from those currently anticipated due to a number of factors and risks.

Wellbeing Digital Sciences Announces Q3 Financial Results and Provides Corporate Update

Retrieved on: 
목요일, 6월 16, 2022
Digital, WIP, Industry, Therapy, Drug development, Ketamine, Fourth, Human, FRA, Woman, Lists of diseases, Company, Digital therapeutics, OTC, Borat Subsequent Moviefilm, Mindscape (company), Bipolar, GLOBE, CFO, SQ2, Clinic, Patient, MEDI, NEO, Pharmaceutical industry

2022 will be foundational year that will set the stage for Wellbeing to execute on its strategy in the future, said Najla Guthrie, Wellbeings Chief Executive Officer.

Key Points: 
  • 2022 will be foundational year that will set the stage for Wellbeing to execute on its strategy in the future, said Najla Guthrie, Wellbeings Chief Executive Officer.
  • His extensive financial experience, combined with his strong leadership skills will enable him to make an immediate impact on our business.
  • Wellbeing is in the process of evaluating the addition of complementary mental health services being provided to patients at the Clinic.
  • Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research.